Evidence map›Paper›PMID 35059941›Full record

ArticleJournal of computer-aided molecular design2022

Turbo prediction: a new approach for bioactivity prediction.

Ammar Abdo, Maude Pupin

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of computer-aided molecular design, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ammar AbdoCNRS, Centrale Lille, UMR 9189 CRIStAL, University of Lille, 59000, Lille, France. ammar_utm@yahoo.com.ORCID 0000-0003-4569-2744
Maude PupinCNRS, Centrale Lille, UMR 9189 CRIStAL, University of Lille, 59000, Lille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nowadays, activity prediction is key to understanding the mechanism-of-action of active structures discovered from phenotypic screening or found in natural products. Machine learning is currently one of the most important and rapidly evolving topics in computer-aided drug discovery to identify and design new drugs with superior biological activities. The performance of a predictive machine learning model can be enhanced through the optimal selection of learning data, algorithm, algorithm parameters, and ensemble methods. In this article, we focus on how to enhance the prediction model using the learning data. However, get an option to add more and accurate data is not easy and available in many cases. This motivated us to propose the turbo prediction model, in which nearest neighbour structures are used to increase prediction accuracy. Five datasets, well known in the literature, were used in this article and experimental results show that turbo prediction can improve the quality prediction of the conventional prediction models, particularly for heterogeneous datasets, without any additional effort on the part of the user carrying out the prediction process, and at a minimal computational cost.

Indexed as

Drug DiscoveryMachine LearningAlgorithmsCluster AnalysisDrug discoveryMachine learningSimilarity-based classificationTarget predictionVirtual screening

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.